When measuring the strength of a business, there are nearly limitless metrics available to measure strength. Sales figures, capital, market share, and product design are common gauges used to gain an insight into the health and traction of an organization.
Raj Vora is a Life Sciences Core Market Leader, Responsible for business growth, technical expertise, and account management of the DPR Construction’s life sciences portfolio in the region through project and customer development or project-specific roles. Focused on cGMP manufacturing facilities primarily in the cell and gene therapy market and involved in lab, containment, and other research projects.
Students returning to Towson University for spring term will find that campus has grown by 320,000 square feet.
The Science Complex is now TU’s largest academic structure—significantly larger than Smith Hall’s 220,000 square feet. It includes 50 teaching laboratories, 30 research laboratories, 50 classrooms, eight lecture halls, 10 collaborative student spaces, an outdoor classroom leading to the Glen Arboretum, a rooftop greenhouse complex, a new planetarium and an observatory.
“The completion of the new science complex marks the result of years of planning and effort from our faculty, staff and partners, including the University System of Maryland Board of Regents, Chancellor Jay A. Perman, Governor Larry Hogan and our state legislative leaders, who have shown unwavering support to this affirmation of TU’s impact on Maryland,” says President Kim Schatzel. “This impressive complex will bolster TU’s nationally-recognized STEM programming, and will enhance TU’s capacity to fulfill its promise as an anchor institution, supplying prepared leaders to meet Maryland’s workforce demands.”Read the full article at: www.towson.edu
Launched in New York, two-year-old data science company DrugViu, which has created a comprehensive and diverse Real-World Evidence Platform for immunological research, will relocate its headquarters to Northern Virginia.
5 Questions with Amy Adams, Executive Director of the Institute for Biohealth Innovation at George Mason University
As Executive Director of the Institute for Biohealth Innovation at George Mason University, Amy Adams is responsible for nurturing and advancing biohealth research and innovation interests of more than 250 faculty and thousands of students who represent a broad range of academic disciplines. Her role includes fostering partnerships with industry, healthcare, government, and academic partners.